Calcitonin Gene-Related Peptide
Calcitonin Gene-Related Peptide is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
Clinical Characteristics and Pathophysiology of Post-Traumatic Headache
Pharmacologically Triggered Migraine Without Aura and Neuroimaging
CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment
Clinical Trials (5)
Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
Clinical Characteristics and Pathophysiology of Post-Traumatic Headache
Pharmacologically Triggered Migraine Without Aura and Neuroimaging
CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5